Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 18, 2016. The document serves as a transaction notification regarding a Person Discharging Managerial Responsibilities (PDMR) or a person closely associated with them, rather than a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to a specific share transaction notification.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a single transaction involving the acquisition of ordinary shares.
Transaction Details and Commentary
- Transaction Type: Acquisition of Ordinary Shares following the re-investment of dividends paid on July 14, 2016.
- Plan: Company's ShareReward Plan.
- Instrument: Ordinary shares of 25 pence each (ISIN: GB0009252882).
- Price: £16.6373 per share.
- Volume: 37 shares.
- Date: July 14, 2016.
- Location: London Stock Exchange (XLON).
- Individual Involved: Mrs. V A Whyte, Company Secretary.
Investor Verification Checklist
- Verify the total number of shares held by Mrs. V A Whyte post-transaction to assess total exposure.
- Confirm the dividend reinvestment terms of the GSK ShareReward Plan for the 2016 period.
- Check subsequent filings for any additional transactions by the Company Secretary or other PDMRs.